Valuation Ardelyx, Inc.

Stocks

Real-time Estimate Cboe BZX 15:57:38 2026-10-28 EDT			5-day change	1st Jan Change
3.075 ^USD	+2.50%		-2.40%	-47.60%

10-19	Wedbush Cuts Price Target on Ardelyx to $8 From $9, Keeps Outperform Rating	MT
10-12	Ardelyx, Inc. Presents Real-World Data At ACG 2026 Showing Reduced Healthcare Resource Utilization Following IBSRELA Initiation In Adults With IBS-C	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	124	534.3	1,439	1,201	1,417	747.6	-	-
Change	-	330.79%	169.39%	-16.56%	17.96%	-47.23%	-	-
Enterprise Value (EV)	124	534.3	1,439	1,201	1,417	747.6	747.6	747.6
Change	-	330.79%	169.39%	-16.56%	17.96%	-47.23%	0%	0%
P/E	-0.72x	-6.79x	-20.7x	-29.8x	-22.4x	-17x	13.3x	4.05x
PBR	-	-	-	-	-	-	-	-
PEG	-	0.1x	0.7x	0.7x	-0.4x	0.5x	-0x	0x
Capitalization / Revenue	12.3x	10.2x	11.6x	3.6x	3.48x	1.53x	1.2x	0.9x
EV / Revenue	0x	0x	0x	0x	0x	1.53x	1.2x	0.9x
EV / EBITDA	-0x	-0x	-0x	0x	-0x	-23.5x	4.86x	2.33x
EV / EBIT	-0x	-0x	-0x	-0x	-0x	-30.6x	8.03x	3.04x
EV / FCF	-0x	-0x	-	-0x	-0x	-15.6x	9.57x	3.67x
FCF Yield	-125%	-13.1%	-	-3.82%	-3.1%	-6.42%	10.4%	27.2%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	-1.52	-0.42	-0.3	-0.17	-0.26	-0.176	0.225	0.74
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	10.1	52.16	124.5	333.6	407.3	487.2	624.1	834.4
EBITDA ¹	-140.2	-51.86	-48.45	9.431	-37.92	-31.79	153.9	320.2
EBIT ¹	-154.3	-63.76	-63.28	-27.95	-40.98	-24.45	93.07	246
Net income ¹	-158.2	-67.21	-66.07	-39.14	-61.6	-44.04	60.5	200.5
Net Debt	-	-	-	-	-	-	-	-
Reference price ²	1.100	2.850	6.200	5.070	5.830	3.000	3.000	3.000
Nbr of stocks (in thousands)	112,743	187,460	232,138	236,854	242,974	249,188	-	-
Announcement Date	2/28/22	3/2/23	2/22/24	2/20/25	2/19/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ARDELYX, INC.	-17.05x	-	-	-.--%	748M
WUXI APPTEC CO., LTD.	17.08x	6.33x	12.4x	1.75%	63.48B
ARGENX SE	30.03x	7.96x	26.08x	0.05%	54.55B
LONZA GROUP AG	37.03x	6.57x	19.63x	0.87%	53.59B
IQVIA HOLDINGS INC.	35.05x	3.37x	14.55x	-.--%	44.75B
BEONE MEDICINES AG	48.28x	5.55x	30.42x	-.--%	41.62B
REVOLUTION MEDICINES, INC.	-19.33x	186.93x	-20.57x	-.--%	39.91B
CELLTRION, INC.	30.28x	7.94x	20.6x	0.4%	32.47B
GENMAB A/S	36.51x	6.64x	22.27x	-.--%	26.7B
WUXI BIOLOGICS (CAYMAN) INC.	26.96x	5.67x	14.71x	-.--%	23.36B
Average	22.48x	26.33x	15.57x	0.31%	38.12B
Weighted average by Cap.	26.47x	25.23x	15.68x	0.46%